Lipoprotein	B:C0065058
(	I:C0065058
a	I:C0065058
)	I:C0065058
management	O
:	O
lifestyle	O
and	O
hormones	O
.	O

Lipoprotein	O
(	I:C0065058
a	I:C0065058
)	I:C0065058
management	O
:	O
lifestyle	O
and	O
hormones	B:C0019932
.	O

Cardiovascular	B:C0007222
disease	I:C0007222
(	O
Cardiovascular	O
disease	I:C0007222
)	O
continues	O
to	O
be	O
the	O
first	O
cause	O
of	O
mortality	O
developed	O
countries	O
.	O

Cardiovascular	O
disease	I:C0007222
(	O
Cardiovascular	B:C0007222
disease	I:C0007222
)	O
continues	O
to	O
be	O
the	O
first	O
cause	O
of	O
mortality	O
developed	O
countries	O
.	O

Moreover	O
,	O
far	O
from	O
diminishing	O
,	O
the	O
cardiovascular	O
risk	O
factors	O
leading	O
towards	O
the	O
development	O
of	O
Cardiovascular	B:C0007222
disease	I:C0007222
are	O
on	O
the	O
rise	O
.	O

Therefore	O
,	O
the	O
preventive	B:C0150369
and	O
therapeutic	O
management	I:C0087111
which	O
is	O
currently	O
in	O
place	O
is	O
clearly	O
not	O
enough	O
to	O
stop	O
this	O
pandemic	O
.	O

Therefore	O
,	O
the	O
preventive	O
and	O
therapeutic	B:C0087111
management	I:C0087111
which	O
is	O
currently	O
in	O
place	O
is	O
clearly	O
not	O
enough	O
to	O
stop	O
this	O
pandemic	O
.	O

In	O
this	O
context	O
,	O
a	O
major	O
resurgence	O
in	O
interest	O
in	O
lipoprotein	B:C0065058
(	I:C0065058
a	I:C0065058
)	I:C0065058
[	O
lipoprotein	O
(	I:C0065058
a	I:C0065058
)	I:C0065058
]	O
has	O
occurred	O
in	O
light	O
of	O
its	O
association	O
with	O
Cardiovascular	O
disease	I:C0007222
.	O

In	O
this	O
context	O
,	O
a	O
major	O
resurgence	O
in	O
interest	O
in	O
lipoprotein	O
(	I:C0065058
a	I:C0065058
)	I:C0065058
[	O
lipoprotein	B:C0065058
(	I:C0065058
a	I:C0065058
)	I:C0065058
]	O
has	O
occurred	O
in	O
light	O
of	O
its	O
association	O
with	O
Cardiovascular	O
disease	I:C0007222
.	O

In	O
this	O
context	O
,	O
a	O
major	O
resurgence	O
in	O
interest	O
in	O
lipoprotein	O
(	I:C0065058
a	I:C0065058
)	I:C0065058
[	O
lipoprotein	O
(	I:C0065058
a	I:C0065058
)	I:C0065058
]	O
has	O
occurred	O
in	O
light	O
of	O
its	O
association	O
with	O
Cardiovascular	B:C0007222
disease	I:C0007222
.	O

This	O
series	O
aims	O
to	O
review	O
the	O
basic	O
and	O
clinical	O
aspects	O
of	O
lipoprotein	B:C0065058
(	I:C0065058
a	I:C0065058
)	I:C0065058
biology	O
.	O

This	O
series	O
aims	O
to	O
review	O
the	O
basic	O
and	O
clinical	O
aspects	O
of	O
lipoprotein	O
(	I:C0065058
a	I:C0065058
)	I:C0065058
biology	B:C0005532
.	O

Specifically	O
,	O
the	O
present	O
review	O
considers	O
the	O
current	O
situation	O
regarding	O
the	O
influence	O
of	O
lifestyle	O
,	O
hormones	B:C0019932
and	O
other	O
physiological	O
or	O
pathological	O
conditions	I:C0039058
on	O
lipoprotein	O
(	I:C0065058
a	I:C0065058
)	I:C0065058
plasma	O
concentrations	O
which	O
might	O
mitigate	O
the	O
harmful	O
effects	I:C0879626
of	O
this	O
lipoprotein	O
.	O

Specifically	O
,	O
the	O
present	O
review	O
considers	O
the	O
current	O
situation	O
regarding	O
the	O
influence	O
of	O
lifestyle	O
,	O
hormones	O
and	O
other	O
physiological	O
or	O
pathological	B:C0039058
conditions	I:C0039058
on	O
lipoprotein	O
(	I:C0065058
a	I:C0065058
)	I:C0065058
plasma	O
concentrations	O
which	O
might	O
mitigate	O
the	O
harmful	O
effects	I:C0879626
of	O
this	O
lipoprotein	O
.	O

Specifically	O
,	O
the	O
present	O
review	O
considers	O
the	O
current	O
situation	O
regarding	O
the	O
influence	O
of	O
lifestyle	O
,	O
hormones	O
and	O
other	O
physiological	O
or	O
pathological	O
conditions	I:C0039058
on	O
lipoprotein	B:C0065058
(	I:C0065058
a	I:C0065058
)	I:C0065058
plasma	O
concentrations	O
which	O
might	O
mitigate	O
the	O
harmful	O
effects	I:C0879626
of	O
this	O
lipoprotein	O
.	O

Specifically	O
,	O
the	O
present	O
review	O
considers	O
the	O
current	O
situation	O
regarding	O
the	O
influence	O
of	O
lifestyle	O
,	O
hormones	O
and	O
other	O
physiological	O
or	O
pathological	O
conditions	I:C0039058
on	O
lipoprotein	O
(	I:C0065058
a	I:C0065058
)	I:C0065058
plasma	O
concentrations	O
which	O
might	O
mitigate	O
the	O
harmful	B:C0879626
effects	I:C0879626
of	O
this	O
lipoprotein	O
.	O

Specifically	O
,	O
the	O
present	O
review	O
considers	O
the	O
current	O
situation	O
regarding	O
the	O
influence	O
of	O
lifestyle	O
,	O
hormones	O
and	O
other	O
physiological	O
or	O
pathological	O
conditions	I:C0039058
on	O
lipoprotein	O
(	I:C0065058
a	I:C0065058
)	I:C0065058
plasma	O
concentrations	O
which	O
might	O
mitigate	O
the	O
harmful	O
effects	I:C0879626
of	O
this	O
lipoprotein	B:C0023820
.	O

